Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.

OBJECTIVE: The corticotrophin-releasing hormone (CRH) stimulation test has become established as a powerful tool in differentiating the source of ACTH in patients with Cushing's syndrome. Psychiatric symptoms are common in patients with Cushing's syndrome, and many patients with psychiatri...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Korbonits, M, Trainer, P, Edwards, R, Besser, G, Grossman, AB
Natura:	Journal article
Lingua:	English
Pubblicazione:	1995

Documenti analoghi

BENZODIAZEPINES ATTENUATE THE SERUM CORTISOL RESPONSE TO CORTICOTROPIN-RELEASING HORMONE (CRH) IN HEALTHY-VOLUNTEERS
di: Trainer, P, et al.
Pubblicazione: (1992)

An analogue of met-enkephalin attenuates the pituitary-adrenal response to ovine corticotrophin releasing factor.
di: Grossman, A, et al.
Pubblicazione: (1986)

The role of corticotrophin-releasing hormone in the diagnosis of Cushing's syndrome
di: Peters, C, et al.
Pubblicazione: (2006)

The effect of growth hormone secretagogues on the release of growth hormone-releasing hormone, somatostatin, vasopressin, and corticotrophin-releasing hormone from the rat hypothalamus in vitro
di: Korbonits, M, et al.
Pubblicazione: (1998)

A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
di: Trainer, P, et al.
Pubblicazione: (1995)

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
di: Sohaib, SA, et al.
Pubblicazione: (1999)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
di: Korbonits, M, et al.
Pubblicazione: (1999)

Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
di: Lytras, N, et al.
Pubblicazione: (1984)

Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
di: Mozid, A, et al.
Pubblicazione: (2003)

Endotoxin, prostanoids and corticotrophin-releasing hormone: an integrated view.
di: Navarra, P, et al.
Pubblicazione: (2001)

Adrenergic stimulation of the human pituitary-adrenal axis is attenuated by an analog of met-enkephalin.
di: Delitala, G, et al.
Pubblicazione: (1991)

Involvement of calmodulin in depolarization-induced release of corticotrophin-releasing hormone-41 from the rat hypothalamus in vitro.
di: Tsagarakis, S, et al.
Pubblicazione: (1991)

The effect of ovine corticotrophin-releasing factor on the hormonal response to insulin-induced hypoglycaemia.
di: Howlett, T, et al.
Pubblicazione: (1989)

Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity.
di: Korbonits, M, et al.
Pubblicazione: (1997)

Adrenal incidentaloma: subclinical Cushing's syndrome.
di: Newell-Price, J, et al.
Pubblicazione: (1996)

The release of leptin and its effect on hormone release from human pituitary adenomas.
di: Korbonits, M, et al.
Pubblicazione: (2001)

The effect of enkephalin analogue on pituitary hormone release in human obesity.
di: Finer, N, et al.
Pubblicazione: (1987)

Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling.
di: Martins, R, et al.
Pubblicazione: (2012)

The cortisol response to corticotrophin-releasing factor is blunted in obesity.
di: Kopelman, P, et al.
Pubblicazione: (1988)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
di: Korbonits, M, et al.
Pubblicazione: (1996)

Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus.
di: Tsagarakis, S, et al.
Pubblicazione: (1989)

Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants.
di: Costa, A, et al.
Pubblicazione: (1997)

The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome.
di: Jenkins, P, et al.
Pubblicazione: (1995)

The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.
di: Newell-Price, J, et al.
Pubblicazione: (1998)

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
di: Looij, B, et al.
Pubblicazione: (1986)

Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations.
di: Dupuis, C, et al.
Pubblicazione: (2007)

Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.
di: Delitala, G, et al.
Pubblicazione: (1994)

Isolated ACTH deficiency with absent response to corticotrophin-releasing factor--41. Evidence for a primary pituitary defect.
di: Murch, S, et al.
Pubblicazione: (1991)

Response of luteinizing hormone from columns of dispersed rat pituitary cells to a highly potent analogue of luteinizing hormone releasing hormone.
di: Yeo, T, et al.
Pubblicazione: (1981)

Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
di: Isidori, A, et al.
Pubblicazione: (2002)

Acceleration of pubertal development following pituitary radiotherapy for Cushing's disease.
di: Nicholl, R, et al.
Pubblicazione: (1993)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
di: Korbonits, M, et al.
Pubblicazione: (1999)

Pituitary-targeted medical therapy of Cushing's disease
di: Alexandraki, K, et al.
Pubblicazione: (2008)

Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy.
di: Chan, L, et al.
Pubblicazione: (2007)

Corticotrophin releasing factor: effects on circulating gut and pancreatic peptides in man.
di: Lytras, N, et al.
Pubblicazione: (1984)

Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rhythm.
di: Grossman, A, et al.
Pubblicazione: (1982)

Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro.
di: Costa, A, et al.
Pubblicazione: (1993)

Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects.
di: Ur, E, et al.
Pubblicazione: (1991)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
di: Trainer, P, et al.
Pubblicazione: (1992)

Novel regulators of the in vitro release of hypothalamic corticotrophin-releasing hormone two decades after its discovery: a review.
di: Costa, A, et al.
Pubblicazione: (2001)